Cerus (CERS) Competitors $1.38 +0.03 (+1.85%) As of 01:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CERS vs. STAA, OSUR, UTMD, ANIK, WST, COO, ALGN, MMSI, HAE, and ICUIShould you be buying Cerus stock or one of its competitors? The main competitors of Cerus include STAAR Surgical (STAA), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), and ICU Medical (ICUI). These companies are all part of the "health care supplies" industry. Cerus vs. Its Competitors STAAR Surgical OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems Haemonetics ICU Medical STAAR Surgical (NASDAQ:STAA) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, media sentiment and valuation. Do insiders and institutionals have more ownership in STAA or CERS? 96.7% of STAAR Surgical shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 1.0% of STAAR Surgical shares are held by company insiders. Comparatively, 3.4% of Cerus shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Do analysts prefer STAA or CERS? STAAR Surgical currently has a consensus price target of $18.00, suggesting a potential upside of 4.83%. Cerus has a consensus price target of $3.50, suggesting a potential upside of 154.55%. Given Cerus' stronger consensus rating and higher possible upside, analysts clearly believe Cerus is more favorable than STAAR Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score STAAR Surgical 0 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.10Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, STAA or CERS? STAAR Surgical has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500. Does the media favor STAA or CERS? In the previous week, STAAR Surgical had 5 more articles in the media than Cerus. MarketBeat recorded 6 mentions for STAAR Surgical and 1 mentions for Cerus. Cerus' average media sentiment score of 1.87 beat STAAR Surgical's score of 0.83 indicating that Cerus is being referred to more favorably in the news media. Company Overall Sentiment STAAR Surgical Positive Cerus Very Positive Which has better earnings & valuation, STAA or CERS? STAAR Surgical has higher revenue and earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSTAAR Surgical$313.90M2.71-$20.21M-$1.44-11.92Cerus$180.27M1.46-$20.92M-$0.10-13.75 Is STAA or CERS more profitable? Cerus has a net margin of -10.23% compared to STAAR Surgical's net margin of -25.46%. STAAR Surgical's return on equity of -10.59% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets STAAR Surgical-25.46% -10.59% -8.32% Cerus -10.23%-34.81%-9.68% SummarySTAAR Surgical and Cerus tied by winning 8 of the 16 factors compared between the two stocks. Get Cerus News Delivered to You Automatically Sign up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CERS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CERS vs. The Competition Export to ExcelMetricCerusMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$262.85M$10.19B$5.56B$9.30BDividend YieldN/A2.09%4.23%4.03%P/E Ratio-13.7516.9728.6119.64Price / Sales1.4628.48437.49188.30Price / CashN/A22.6736.0257.93Price / Book4.443.608.185.63Net Income-$20.92M$233.40M$3.23B$257.73M7 Day Performance-7.72%-2.88%-0.25%0.07%1 Month Performance-2.48%1.60%5.40%8.32%1 Year Performance-42.47%-19.42%26.35%13.78% Cerus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CERSCerus2.6209 of 5 stars$1.38+1.9%$3.50+154.5%-40.0%$262.85M$180.27M-13.75290Positive NewsSTAASTAAR Surgical3.3268 of 5 stars$17.30-0.5%$24.63+42.3%-62.7%$856.87M$313.90M-12.011,211Analyst ForecastGap UpOSUROraSure Technologies2.5146 of 5 stars$3.07-1.0%$3.00-2.3%-27.7%$229.64M$185.83M-7.31840High Trading VolumeUTMDUtah Medical Products2.2264 of 5 stars$56.69+0.5%N/A-18.8%$184.24M$40.90M15.00180ANIKAnika Therapeutics4.29 of 5 stars$11.53+2.3%$20.00+73.5%-60.1%$165.35M$117.05M-2.97300WSTWest Pharmaceutical Services4.7881 of 5 stars$224.66-1.1%$320.00+42.4%-31.0%$16.14B$2.89B35.2710,600Positive NewsCOOCooper Companies3.2365 of 5 stars$73.61-1.6%$99.70+35.4%-18.6%$14.72B$3.90B35.7316,000Analyst ForecastALGNAlign Technology4.8423 of 5 stars$199.31-1.5%$242.92+21.9%-19.8%$14.45B$4.00B36.3020,945Positive NewsMMSIMerit Medical Systems4.2181 of 5 stars$93.450.0%$109.11+16.8%+9.3%$5.52B$1.36B45.817,400Positive NewsHAEHaemonetics4.886 of 5 stars$76.59+1.4%$97.30+27.0%-17.3%$3.68B$1.36B23.143,023Analyst RevisionICUIICU Medical4.3451 of 5 stars$130.85-1.0%$192.67+47.2%+0.6%$3.22B$2.42B-34.1615,000Positive News Related Companies and Tools Related Companies STAA Competitors OSUR Competitors UTMD Competitors ANIK Competitors WST Competitors COO Competitors ALGN Competitors MMSI Competitors HAE Competitors ICUI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CERS) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersDrilling With a $3.5B Discovery Partner in Its CornerA small-cap explorer is about to drill for high-grade gold in a region known for multi-million-ounce discoveri...The Tomorrow Investor | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerus Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
